Markets:

Overview

News

Currencies

International

Treasuries

Outlook Therapeutics, Inc. - Common Stock (NQ:OTLK)

0.5521 +0.0299 (+5.73%)

Streaming Delayed Price Updated: 1:21 PM EST, Jan 16, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Outlook Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

August 30, 2023

Via Benzinga

Why Is Brookfield Real Assets (RA) Stock Down 24% Today? ↗

August 30, 2023

Brookfield Real Assets (RA) stock is falling hard on Thursday after the fixed-income mutual fund lowered its monthly distributions.

Via InvestorPlace

Why Is Outlook Therapeutics (OTLK) Stock Down 78% Today? ↗

August 30, 2023

Outlook Therapeutics (OTLK) stock is taking a beating on Wednesday after getting a rejection letter from the FDA for its wet AMD treatment..

Via InvestorPlace

Why Is Outlook Therapeutics Stock Nosediving Today? ↗

August 30, 2023

Outlook Therapeutics Inc (NASDAQ: OTLK) shares are falling after the company received an FDA complete response letter regarding ONS-5010, an investigational ophthalmic formulation of bevacizumab under...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

August 30, 2023

Pre-market stock movers are a hot topic on Wednesday morning and we're covering the shares rising and falling this morning!

Via InvestorPlace

Why Shares of Outlook Therapeutics Rose Tuesday ↗

June 06, 2023

The healthcare stock hit a 52-week high for the second consecutive day.

Via The Motley Fool

Analyst Expectations for Outlook Therapeutics's Future ↗

April 03, 2023

Via Benzinga

Box, Ambarella, HP And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗

August 30, 2023

U.S. stock futures traded lower this morning on Wednesday. Here are some big stocks recording losses in today’s pre-market trading session.

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

August 28, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For July 13, 2023 ↗

July 13, 2023

Via Benzinga

Earnings Outlook For Outlook Therapeutics ↗

December 26, 2022

Via Benzinga

Why THOR Industries Shares Are Trading Higher By 15%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

June 06, 2023

Gainers Recruiter.com Group, Inc. (NASDAQ: RCRT) shares jumped 114% to $0.41. Recruiter.com signed a definitive agreement for planned purchase of fintech assets of GoLogiq.

Via Benzinga

Top 5 Health Care Stocks That Could Sink Your Portfolio This Quarter ↗

June 06, 2023

The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.

Via Benzinga

Why Microvast Holdings Shares Are Trading Lower By Around 22%; Here Are 20 Stocks Moving Premarket ↗

May 23, 2023

Gainers Applied UV, Inc. (NASDAQ: AUVI) shares rose 44.6% to $0.69 in pre-market trading after posting better-than-expected quarterly sales.

Via Benzinga

Why ZIM Integrated Shipping Services Shares Are Trading Lower By 14%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

May 22, 2023

Gainers Greenhill & Co., Inc. (NYSE: GHL) shares jumped 116.4% to $14.67 after Mizuho announced it would acquire the company for $15 per share.

Via Benzinga

Why IDEAYA Biosciences Shares Are Trading Higher By Around 27%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

April 24, 2023

Gainers Aclarion, Inc. (NASDAQ: ACON) shares surged 152% to $1.85 amid the publication of durability data for the company's back pain treatment.

Via Benzinga

Super Micro Computer, Garrett Motion, Rackspace Technology And Other Big Stocks Moving Lower On Monday ↗

April 24, 2023

U.S. stocks traded mixed, with the Nasdaq Composite dropping around 50 points on Monday. Here are some big stocks recording losses in today’s session.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For April 3, 2023 ↗

April 03, 2023

Via Benzinga

JTC Team to Host the Virtual Investor 2023 Companies to Watch Event on January 17th, 18th, and 19th

January 11, 2023

Via ACCESSWIRE

Benzinga's Top Ratings Upgrades, Downgrades For February 6, 2023 ↗

February 06, 2023

Via Benzinga

What's Next For Stocks After S&P 500 Wraps Roughest Year Since 2008? ↗

December 30, 2022

The SPDR S&P 500 ETF Trust (NYSE: SPY) 500 declined for the fourth consecutive week as the stock market completed its worst year in more than a decade.

Via Benzinga

Earnings Scheduled For December 27, 2022 ↗

December 27, 2022

Companies Reporting Before The Bell • Outlook Therapeutics (NASDAQ:OTLK) is expected to report earnings for its fourth quarter. This article was generated by Benzinga's automated content engine and...

Via Benzinga

Can The Economy Weather Inflation, A Winter Storm, Elon Musk? ↗

December 23, 2022

The S&P 500 traded lower for the third consecutive week on concerns inflation may be more stubborn than anticipated.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

November 15, 2022

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For October 31, 2022 ↗

October 31, 2022

Upgrades

Via Benzinga

TRACON Pharmaceuticals And 2 Other Stocks Under $2 Insiders Are Aggressively Buying ↗

October 06, 2022

US gold futures traded slightly higher this morning on Wednesday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

September 27, 2022

Gainers Benitec Biopharma (NASDAQ:BNTC) shares increased by 9.8% to $0.35 during Tuesday's after-market session. The company's market cap stands at $9.0 million.

Via Benzinga

A Major October Catalyst Could Make This Eye Stock A Ten Bagger, Analyst Says ↗

September 13, 2022

Chardan initiated coverage on Outlook Therapeutics Inc (NASDAQ: OTLK) with a Buy rati

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 13, 2022 ↗

September 13, 2022

Upgrades See all analyst ratings upgrades.

Via Benzinga

Recap Of Tuesday's Biotech Catalysts - End Of the Day Summary ↗

August 30, 2022

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.